GLP-1s & the Trade Offs of Weight Loss Drugs

“What do we do about GLP-1s?” A CFO recently asked me (after seeing their health plan has an additional $300k of annual cost from the uptick in GLP-1s). 

Well that’s tricky - we know the cost is currently around $1,000/month. We know over 70 companies are working through the FDA approval process. We expect this will bring the cost down - which begs the question. 

At what point is their financial incentive to make the investment (to cover weight loss drugs) in your workforce? Tangibly, as a fiduciary, would you be willing to invest $5,000/yr into an employee if it significantly reduced the chances of future comorbidities?

What can we do to increase behavioral change in tandem?

These are intriguing and sensitive conversations that all leadership teams will be, if not already, considering. 

Music by Alex Lambert.

Contact Justin via text 740-525-5259 or via email JFutrell@TrueNorthCompanies.com

I welcome the opportunity to hear your feedback from this episode!

Thanks again to my musically gifted friend Alex Lambert for the music. Also thanks to Kevin Asehan for the edits.